Parkman Healthcare Partners LLC Lexicon Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $205,855 - $452,492	-194,203 Reduced 14.59%	1,136,413 $1.24 Million
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $1.41 Million - $2.29 Million	655,288 Added 97.03%	1,330,616 $3.05 Million
Q1 2023 May 12, 2023	BUY	$1.99 - $2.68 $505,710 - $681,057	254,126 Added 60.33%	675,328 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $211,658 - $301,025	117,588 Added 38.73%	421,202 $804,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $104,011 - $183,896	53,614 Added 21.45%	303,614 $729,000
Q2 2022 Aug 12, 2022	BUY	$1.31 - $2.69 $327,500 - $672,500	250,000 New	250,000 $465,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.